2 EBQ Boggio for all periods bipolar and therapy 25 26

Using the sources provided, develop and justify an argument about the comparative effectiveness of various treatment strategies in managing bipolar disorder across diverse patient groups.

A. Propose a specific and defensible claim based in psychological science that responds to the question.

B(i) Support your claim using at least one piece of specific and relevant evidence from one of the sources.

B(ii) Explain how the evidence from Part B (i) supports your claim using a psychological perspective, theory, concept, or research finding learned in AP Psychology.

C(i) Support your claim using an additional piece of specific and relevant evidence from a different source than the one that was used in Part B (i).

C(ii) Explain how the evidence from Part C (i) supports your claim using a different psychological perspective, theory, concept, or research finding learned in AP Psychology than the one used in Part B (ii).

Source A Introduction

This longitudinal study rigorously examines the comparative effectiveness of combining medication and cognitive-behavioral therapy (CBT) against medication-only treatments for bipolar disorder. Specifically, it evaluates whether a dual-treatment approach results in decreased relapse rates and superior mood stabilization over a period of two years.

Participants

A cohort of 400 patients diagnosed with bipolar disorder, ranging from 18 to 55 years old, were recruited from psychiatric outpatient facilities in New York, Los Angeles, Chicago, and Houston. The participants were stratified by age, gender, and severity of condition before being randomly allocated to one of two treatment groups: 200 participants received the combined treatment of medication and CBT, and 200 received only medication.

Method

The methodology was designed to monitor and compare outcomes across the two groups rigorously:

Medication Dosage and Monitoring: All participants in the medication group received lithium carbonate, dosed initially at 900 mg daily and adjusted up to 1500 mg to achieve and maintain therapeutic blood levels of 0.6 to 1.2 mEq/L, as verified by bi-weekly blood tests.

CBT Implementation: Participants in the combined treatment group additionally received weekly CBT sessions during the first year, which were reduced to bi-weekly sessions during the second year, focusing on coping strategies, mood regulation, and relapse prevention.

Outcome Measures: Relapse rates were recorded based on the frequency of manic and depressive episodes per year. Mood stability was assessed monthly using a composite index derived from the Hamilton Depression Rating Scale and the Young Mania Rating Scale scores.

Results and Discussion

The two-year follow-up revealed that the combination therapy group experienced significantly fewer average annual relapses (0.7 vs. 1.0, p < 0.01) and maintained higher mood stability scores (average index score: 75 vs. 58, p < 0.001) compared to the medication-only group.

Statistical analyses, including ANOVA and regression models, supported the initial hypothesis, indicating the superior efficacy of the integrated treatment approach in managing and stabilizing bipolar disorder symptoms.

Adapted from Johnson, M., & Lee, P. (2018). Evaluating the Effectiveness of Combined Medication and Cognitive-Behavioral Therapy in Bipolar Disorder Management. Journal of Clinical Psychiatry and Neuroscience, 46(1), 112-130.

Source B Introduction

This double-blind, randomized controlled trial evaluates the efficacy of a novel mood-stabilizing drug, MoodX, in comparison to standard lithium treatment, with a focus on patients diagnosed with the rapid cycling variant of bipolar disorder.

Participants

Two hundred fifty patients with confirmed rapid cycling bipolar disorder were enrolled from five university-affiliated psychiatric centers. Each participant underwent a comprehensive medical and psychiatric evaluation to ensure compliance with the study criteria.

Method

The participants were randomly assigned to one of two groups:

MoodX Group: 125 patients received MoodX, starting at a 100 mg dose and adjusted up to 400 mg based on therapeutic response and side effects.

Lithium Group: 125 patients continued on a controlled lithium regimen aimed at maintaining plasma levels between 0.8 and 1.2 mEq/L.

Efficacy Assessment: Every two months, the Bipolar Disorder Severity Index (BDSI) was administered to measure symptom changes, while the Bipolar Disorder Quality of Life Scale (BDQLS) was used quarterly to assess life quality improvements.

Statistical Analysis: Data were analyzed using repeated measures ANOVA to compare the time-course changes in BDSI and BDQLS scores across both groups.

Results and Discussion

After 12 months, the MoodX group showed a faster and more significant reduction in BDSI scores compared to the lithium group (average reduction: 40% vs. 25%, p < 0.05). Additionally, improvements in BDQLS scores were more pronounced in the MoodX group, indicating enhanced quality of life. These results suggest that MoodX may offer a more effective alternative for managing severe symptoms associated with rapid cycling bipolar disorder, with potential implications for future treatment protocols.

Adapted from Thompson, R., & Gupta, S. (2016). A Comparative Study of MoodX versus Lithium Treatment for Rapid Cycling Bipolar Disorder. Bipolar Disorders International, 19(3), 234-252.

AP Psychology - EBQ 5 ©Morgan AP Teaching

Source C Introduction

This randomized controlled trial assesses the impact of peer support interventions compared to standard psychiatric care on the long-term management of bipolar disorder, focusing particularly on patient adherence to treatment protocols and overall mental health outcomes.

Participants

Three hundred patients diagnosed with various forms of bipolar disorder were recruited from ten community mental health centers across the United States. Participants were predominantly in the 25-40 year age group, reflecting the demographic most commonly affected by the onset of bipolar symptoms.

Method

Participants were randomly assigned into three groups:

Peer Support Group: 100 patients received standard medical treatment along with bi-weekly sessions of peer-supported group therapy, which included shared experiences, emotional support, and coping strategies.

Control Group: 100 patients received standard medical treatment without additional support.

Enhanced Peer Support Group: 100 patients received standard treatment and weekly sessions of peer support plus additional monthly workshops on lifestyle management and stress reduction.

Assessment Tools: Treatment adherence was monitored through monthly interviews and pharmacy records, while mental health outcomes were evaluated using the General Health Questionnaire and the Bipolar Stability Index every quarter.

Results and Discussion

The study found that the Enhanced Peer Support Group exhibited the highest treatment adherence rates (95% vs. 75% in the Peer Support Group and 65% in the Control Group, p < 0.01) and significantly better scores on mental health outcomes. This group also reported a 50% reduction in hospital readmissions compared to the other groups, suggesting that intensive peer support combined with traditional medical care can lead to superior management of bipolar disorder.

Adapted from Martinez, E., & Zhang, H. (2014). Long-Term Outcomes of Peer Support Interventions in Bipolar Disorder Treatment. Mental Health Review Journal, 30(4), 401-422.

Part A: Propose a specific and defensible claim based in psychological science that responds to the question.

Part B (i): Support your claim using at least one piece of specific and relevant evidence from one of the sources.

Part B (ii): Explain how the evidence from Part B (i) supports your claim using a psychological perspective, theory, concept, or research finding learned in AP Psychology.

Part C (i): Support your claim using an additional piece of specific and relevant evidence from a different source than the one that was used in Part B (i).

Part C (ii): Explain how the evidence from Part C (i) supports your claim using a different psychological perspective, theory, concept, or research finding learned in AP Psychology than the one that was used in Part B (ii).